Human iPS cell-derived dopaminergic neurons function in a primate Parkinson’s disease model
The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Induced pluripotent stem cells (iPS cells) are a promising source for a cell-based therapy to treat Parkinson's disease (PD), in which midbrain dopaminergic neurons progressively degenerate. However, long-term analysis of human iPS cell-derived dopaminergic neurons in primate PD models has never been performed to our knowledge. Here we show that human iPS cell-derived dopaminergic progenitor cells survived and functioned as midbrain dopaminergic neurons in a primate model of PD (Macaca fascicularis) treated with the neurotoxin MPTP. Score-based and video-recording analyses revealed an increase in spontaneous movement of the monkeys after transplantation. Histological studies showed that the mature dopaminergic neurons extended dense neurites into the host striatum; this effect was consistent regardless of whether the cells were derived from patients with PD or from healthy individuals. Cells sorted by the floor plate marker CORIN did not form any tumours in the brains for at least two years. Finally, magnetic resonance imaging and positron emission tomography were used to monitor the survival, expansion and function of the grafted cells as well as the immune response in the host brain. Thus, this preclinical study using a primate model indicates that human iPS cell-derived dopaminergic progenitors are clinically applicable for the treatment of patients with PD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Morizane et al. and Kikuchi et al. both showed that an improvement of engraftment and reduced immune reaction were observed using MHC matching of iPSC-derived dopaminergic neurons in unlesioned non-human primates [98,99].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [99]
In the citing paper
“A comprehensive study of human iPSC-derived dopamine neuron progenitor cells expressing specific markers of the neural floor plate (CORIN+; FOXA2+; TUJ1+; PAX6−) and transplanted into a monkey model of Parkinson’s disease showed stronger evidence of behavioural benefits, of cellular integration of mature dopamine neurons within the putamen, and of extension of their dense neurites into the host st”
From How to design preclinical studies in nanomedicine and cell therapy to maximize the prospects of clinical translation (2018) · cites this paper as [82]
In the citing paper
“Most of the transplanted cells expressed FOXA2 and a third expressed tyrosine hydroxylase consistent with mature functional dopamine neurons.”
From How to design preclinical studies in nanomedicine and cell therapy to maximize the prospects of clinical translation (2018) · cites this paper as [82]
Citations
Cites
Advances in functional and structural MR image analysis and implementation as FSL
Smith, S. M., Jenkinson, M., Woolrich, M. W., Beckmann, C. F., Behrens, T. E. J., Johansen-Berg, H., Bannister, P. R., De Luca, M., Drobnjak, I., Flitney, D. E., et al. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.07.051 · Cited by 13,630
Jenkinson, M., Bannister, P., Brady, M., & Smith, S. (2002) · NeuroImage · doi:10.1006/nimg.2002.1132 · Cited by 11,888
Fast robust automated brain extraction
Smith, S. M. (2002) · Human Brain Mapping · doi:10.1002/hbm.10062 · Cited by 10,496
Zhang, Y., Brady, M., & Smith, S. (2001) · IEEE Transactions on Medical Imaging · doi:10.1109/42.906424 · Cited by 6,982
A global optimisation method for robust affine registration of brain images
Jenkinson, M., & Smith, S. (2001) · Medical Image Analysis · doi:10.1016/s1361-8415(01)00036-6 · Cited by 6,872
Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling
Chambers, S. M., Fasano, C. A., Papapetrou, E. P., Tomishima, M., Sadelain, M., & Studer, L. (2009) · Nature Biotechnology · doi:10.1038/nbt.1529 · Cited by 3,620
Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data
Patlak, C. S., Blasberg, R. G., & Fenstermacher, J. D. (1983) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1983.1 · Cited by 3,567
Transplantation of Embryonic Dopamine Neurons for Severe Parkinson's Disease
Freed, C. R., Greene, P. E., Breeze, R. E., Tsai, W.-Y., DuMouchel, W., Kao, R., Dillon, S., Winfield, H., Culver, S., Trojanowski, J. Q., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441002 · Cited by 2,366
Kriks, S., Shim, J.-W., Piao, J., Ganat, Y. M., Wakeman, D. R., Xie, Z., Carrillo-Reid, L., Auyeung, G., Antonacci, C., Buch, A., et al. (2011) · Nature · doi:10.1038/nature10648 · Cited by 1,907
Patlak, C. S., & Blasberg, R. G. (1985) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1985.87 · Cited by 1,673
Cited by
Items 501–600 of 705
Melanocyte stem cells in skin diseases and their potential in cell-based therapy.
Wang, Z., Liu, L., & Zheng, Y. (2022) · PubMed · doi:10.14670/hh-18-470 · Cited by 7
Gene-modified neural progenitor cells for the treatment of neuropathic lysosomal storage diseases
Mandolfo, O., & Bigger, B. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.367845 · Cited by 3
Role of Stem Cells as a Protective Agent against Neurological Complications
Nayeem, U., Ahmed, S., Kumar, D., Jahan, S., Khan, A., Rather, G. A., & Siddiqui, A. J. (2023) · Springer eBooks · doi:10.1007/978-981-99-3848-3_4 · Cited by 4
Chandrababu, K., Radhakrishnan, V., Anjana, A. S., Rajan, R. S., Sivan, U., Krishnan, S., & Chakrapani, P. S. B. (2023) · Experimental Brain Research · doi:10.1007/s00221-023-06735-1 · Cited by 3
“The long-term efficiency and safety of DA neurons derived from iPSCs have been demonstrated in various pre-clinical studies (Hallett et al. 2015; Wang et al. 2015; Wakeman et al. 2017; Kikuchi et al. 2017; Doi et al. 2020).”
The role of personalized precision medicine in enhancing diagnostic accuracy and clinical outcomes
Sekaran, S. D., Manikam, R., Thergerajan, G., Prasad, H., Alagar, M., & Tan, C. K. (2025) · Advances in Biomedical and Health Sciences · doi:10.4103/abhs.abhs_105_24 · Cited by 3
Uchiumi, F. (2018) · InTech eBooks · doi:10.5772/intechopen.71701 · Cited by 4
Nakamura, Y., & Shimizu, Y. (2019) · Advances in experimental medicine and biology · doi:10.1007/5584_2019_394 · Cited by 3
Synaptic signalling in a network of dopamine neurons: what prevents proper intercellular crosstalk?
Chen, Y., Kunath, T., Simpson, J., Homer, N. Z. M., & Sylantyev, S. (2020) · FEBS Letters · doi:10.1002/1873-3468.13910 · Cited by 3
The application of iPSCs in Parkinson’s disease
Nielsen, J. J. J., Lillethorup, T. P., Glud, A. N., Sørensen, J. C. H., & Orłowski, D. (2020) · Acta Neurobiologiae Experimentalis · doi:10.21307/ane-2020-024 · Cited by 3
Niu, Q., & Xu, W. (2022) · Applied Bionics and Biomechanics · doi:10.1155/2022/8168152 · Cited by 3
RetractedRecent Advances in Neurodegeneration
Borreca, A. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.71995 · Cited by 3
Klimanskaya, I. V., Kimbrel, E. A., & Lanza, R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818422-6.00024-1 · Cited by 7
‘Reprogrammed’ stem cells to be tested in people with Parkinson’s
Cyranoski, D. (2018) · Nature · doi:10.1038/d41586-018-05856-w · Cited by 3
Evaluation of Evidence: Stem Cells as a Treatment Option for Traumatic Brain Injury
Tabet, M., Hasan, H. A., Abdelhady, S., Mahavadi, A. K., Clervius, H., Nasrallah, L., Ahmad, F., Shaito, N., Ramakrawala, R., Zibara, K., et al. (2020) · Wiley eBooks · doi:10.1002/9780470015902.a0025801 · Cited by 3
Birtele, M., Sharma, Y., Storm, P., Kajtez, J., Wahlestedt, J. N., Sozzi, E., Nilsson, F., Stott, S., He, X., Mattsson, B., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.01.322495 · Cited by 3
Self-citationTwo parallel lineage-committed progenitors contribute to the developing brainPreprint
Dundes, C. E., Jokhai, R. T., Ahsan, H. S., Kang, R. S., Salomon, R. E. A., Rajan, A., Kim, Y. S., Stanton, L. J., Xu, C. L., Do, S., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.02.662771 · Cited by 3
Non‐human primate models of Parkinson's disease: Decoding pathogenesis and advancing therapies
Zhang, S., Yuan, L., Wu, Z., Du, X., Kubiak, J. Z., Yue, F., Yan, X., Jiang, G., & Huang, Y. (2025) · Brain‐X · doi:10.1002/brx2.70032 · Cited by 4
“[51] In these models, the topographic pattern of dopaminergic cell loss in the striatum replicates that of PD.”
Liu, J., Wang, S., Fan, L., Zhou, X., Zhang, S., Wang, Q., Dong, P., & Yu, B. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1615001 · Cited by 5
“Emerging cellular therapies, such as the use of induced pluripotent stem cells, show considerable promise in PD treatment, although patient responses remain variable (83).”
Curle, A. J., Fazal, S. V., Qarin, S., Howlett, S., He, X., Stamper, A., Pisupati, V., Barker, R. A., & Jones, J. (2026) · Stem Cell Reports · doi:10.1016/j.stemcr.2026.102818 · Cited by 4
Zhang, Y., Zang, Z., Zhao, R., Fan, X., Zhang, S., Xie, J., & Zhao, M. (2026) · Journal of Visualized Experiments · doi:10.3791/69884 · Cited by 2
Human pluripotent stem cell engineering with CRISPR–Cas9 for Parkinson’s disease
Park, S. B., Kim, J., Ha, Y., Kim, M. S., & Kim, T. W. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01679-2 · Cited by 3
Pociūtė, A., Tunaitis, V., Zebrauskas, A., Piļipenko, V., Jansone, B., Narbute, K., Pultar, M., Hackl, M., & Pivoriūnas, A. (2026) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szag024 · Cited by 2
BMP/SMAD Pathway and the Development of Dopamine Substantia Nigra Neurons
Kouwenhoven, W. M., & van Heesbeen, H. J. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.0821-18.2018 · Cited by 2
Marjan, S., Yangzom, T., Kristiansen, C. K., Chen, A., Bindoff, L. A., & Liang, K. X. (2023) · Journal of Visualized Experiments · doi:10.3791/65621 · Cited by 2
Jin, M., Shi, R., Gao, D., Wang, B., Li, N., Li, X., Attila Gabor, S. I. K., Liu, K., & Zhang, X. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14407 · Cited by 3
“96 Long-term survival and function of dopaminergic neurons derived from autologous human iPSCs have been reported in non-human primate models of PD. 97,98 In the future, iPSCs might be applied to PD diagnosis by using ErbB2 pY-1248 as a PD biomarker.”
BackgroundBioelectronic medicine potentiates endogenous NSCs for neurodegenerative diseases
Yu, M., Sun, P., Sun, C., & Jin, W. (2023) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2023.08.005 · Cited by 3
Hu, J., Ou-Yang, Z.-Y., Zhao, Y., Zhao, J., Tan, L., Liu, Q., Wang, M.-Y., Ye, Q., Feng, Y., Zhong, M., et al. (2024) · Stem Cell Reviews and Reports · doi:10.1007/s12015-024-10690-x · Cited by 2
“As an important marker for maintaining stem cell homeostasis [26], delta-like homolog 1 (DLK1) serves as an indicator utilized for assessing the efficacy of stem cell transplantation in a clinical setting, in order to anticipate the therapeutic outcomes of the procedure [27].”
Tamura, T., Tahara, T., Inoue, M., Nanjo, R., Onoe, H., Yamamoto, T., & Kawamata, S. (2024) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szae019 · Cited by 2
Self-citationEmborg, M. E., Gambardella, J. C., Zhang, A., & Federoff, H. J. (2024) · Handbook of clinical neurology · doi:10.1016/b978-0-323-90120-8.00010-1 · Cited by 2
Revolutionizing medicine practice using stem cells in healthcare: review article
Acharya, P., & Nyamagoud, S. B. (2024) · MGM Journal of Medical Sciences · doi:10.4103/mgmj.mgmj_155_24 · Cited by 4
Eliasen, J. N., Kristiansen, U., & Kohlmeier, K. A. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149425 · Cited by 2
“…shown to be an excellent model. iPSCs can be derived from patient-specific cells and differentiated into various cell types (including neurons), thus providing a unique opportunity to model human diseases in vitro (Wang et al., 2023, Kikuchi et al., 2017, Wen et al., 2016, Vadodaria et al., 2018).”
Somatic cell reprogramming for Parkinson's disease treatment
Li, X., Fang, K., & Wang, F. (2025) · Ibrain · doi:10.1002/ibra.12189 · Cited by 3
“24,102 With the 4th International Congress of Neuroscience in Kyoto, members of GForce ‐ PD (A Global Effort to Bring Cell ‐ Based Therapies to PD Patients) are nearing or have completed the good manufacturing practice (GMP) in the cell production process.”
InfluentialSogabe, S., Nakano, H., Ogasahara, Y., Cha, P.-C., Ando, Y., Taniguchi‐Ikeda, M., Matsumoto, R., Kanagawa, M., Kobayashi, K., Murayama, S., et al. (2025) · Journal of Human Genetics · doi:10.1038/s10038-025-01335-z · Cited by 4
Kademani, A., Avraam, C., Montenegro, D., Paloh, A., Somannagari, N., Gupta, A., Lafi, A. W., Algaba, A. E., Islam, R., Fahima, C., et al. (2025) · Cureus · doi:10.7759/cureus.89629 · Cited by 4
“A study showed no tumorous growth for 2 years in cells sorted by a floor plate marker called Corin, serine peptidase (CORIN) [53].”
Stem cell-based therapies for neurological disorders
Tamura, R., & Toda, M. (2018) · AIMS Cell and Tissue Engineering · doi:10.3934/celltissue.2018.1.24 · Cited by 2
“Functional effects and safety without forming any tumors for 2 years were demonstrated [51].”
Innovations in Human Stem Cell Research: A Holy Grail for Regenerative Medicine
Liao, Y., Zhu, H., Ivanova, L. B., & Cairo, M. S. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.88790 · Cited by 3
Emerging Methods in Modeling Brain Development and Disease with Human Pluripotent Stem Cells
Allen, G. E., Dhanda, A. S., & Julian, L. M. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2409-8_20 · Cited by 2
Treatment of Parkinson's Disease after the Wearing Off Sets in
Mizuno, Y. (2019) · Journal of Neurology and Neuromedicine · doi:10.29245/2572.942x/2019/1.1241 · Cited by 3
Induced Pluripotent Stem Cells
Mobley, A. S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-811014-0.00004-4 · Cited by 4
Nie, Y. G., Zijun, D., Weiwei, W., Bhuvanesh, T., Ma, N., & Lendlein, A. (2019) · MRS Advances · doi:10.1557/adv.2019.405 · Cited by 2
New approaches to antibacterial drug discovery
Turan, N. B. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818480-6.00008-4 · Cited by 3
CRISPR/Cas System and Stem Cell Editing: Prospects and Possibilities in Veterinary Sciences
Hussain, M. S., & Kumar, M. (2021) · Springer eBooks · doi:10.1007/978-981-16-3464-2_18 · Cited by 2
The NonHuman Primate Neuroimaging & Neuroanatomy ProjectPreprint
Hayashi, T., Hou, Y., Glasser, M. F., Autio, J. A., Knoblauch, K., Inoue‐Murayama, M., Coalson, T., Yacoub, E. S., Smith, S. M., Kennedy, H., et al. (2020) · arXiv (Cornell University) · doi:10.48550/arxiv.2010.00308 · Cited by 2
Self-citationOlmsted, Z. T., Stigliano, C., Scimemi, A., Marzullo, B. J., Wolfe, T., Cibelli, J. B., Horner, P. J., & Paluh, J. L. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.10.374876 · Cited by 3
Azadian, M. M., & George, P. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-820480-1.00040-1 · Cited by 3
Chemically induced in vivo retinal neuron regeneration rescues vision in micePreprint
Shoaib, R. M., Medvidovik, S., Korobkova, L., Tripathi, P., Lin, R. P., Sandrosyan, A., Hariharan, S., & Mahato, B. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.27.572921 · Cited by 2
Human in vitro disease models to aid pathway and target discovery for neurological disorders
Muralidharan, B. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821972-0.00013-7 · Cited by 2
Gubinelli, F., Salazar, J. M., Kaspar, J., Ortiz, I. S., Schafer, S. T., & Burbulla, L. F. (2024) · Neuromethods · doi:10.1007/978-1-0716-4083-8_17 · Cited by 1
Exercise your graft – An important lesson for cell replacement therapy for Parkinson's disease
Daadi, M. M., & Snyder, E. Y. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.115085 · Cited by 1
Immunotherapy for Neurodegenerative Movement Disorders
Mosley, R. L., Saleh, M., & Olson, K. E. (2024) · Springer eBooks · doi:10.1007/978-3-031-68237-7_52 · Cited by 3
Urasawa, T., & Kawasaki, N. (2024) · ACS Omega · doi:10.1021/acsomega.4c06371 · Cited by 1
Paisey, S. J., Jones, L. R., Harrison, D. J., Drummond, N. J., Edwards, O., Canham, M. A., Roberton, V. H., Marshall, C., Parker, G. D., Hills, R., et al. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106910 · Cited by 3
“In primates, hiPSC-derived DA grafted regions have been identified using T2-weighted magnetic resonance (MR) imaging and [ 18 F]fluo-rothymidine (FLT)-PET, which can be used to detect proliferating cells (Kikuchi et al., 2017).”
Origin and Evolution of Induced Pluripotent Stem Cells (IPSCs)
Bandyopadhyay, A. K. (2025) · Magna Scientia Advanced Biology and Pharmacy · doi:10.30574/msabp.2025.15.2.0052 · Cited by 1
Personalized management of Parkinson’s disease
Chakraborty, D., Roy, P. K., Das, R., & Mal, C. (2025) · Progress in brain research · doi:10.1016/bs.pbr.2025.08.007 · Cited by 1
Agarwal, S. (2025) · Journal of High School Science · doi:10.64336/001c.129931 · Cited by 2
Feng, X., Xiao, B., Hou, L., Zhang, B., Tian, L., Mo, B., & Yao, D. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1745174 · Cited by 1
Cell therapy strategies for organ regeneration
Papamichail, L., van der Laan, L. J. W., ZADPOOR, A. A., Lindstedt, S., & Hoogduijn, M. J. (2026) · BMC Medicine · doi:10.1186/s12916-026-04707-0 · Cited by 4
“While this field is still in its infancy, studies in Parkinson’s disease animal models and clinical trials in type 1 diabetes demonstrate that engrafted iPSC-derived dopaminergic neurons [123] and β cells [124, 125], respectively, show functional improvement after engraftment.”
Cell-based regenerative interventions in Parkinson's disease: Overcoming pharmacological limitations
Padilla, A. L., Lanciego, J. L., Vila, M., de Castro, F., Pozo, D., de Fonseca, F. R., Serrano, A., Sáez‐Valero, J., Núñez, L., Villalobos, C., et al. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.03.031 · Cited by 1
“…rats and MPTP-lesioned monkeys resulted in improved DA viability, nigrostriatal connectivity, and behavioral performance, without adverse effects 40 . iPSC-derived neurons from healthy and PD donors enhanced spontaneous activity, cell survival, and DA uptake in MPTP-treated cynomolgus monkeys 41 .”
Nakanishi, E., Yamakado, H., Sawamoto, N., Takahashi, J., & Takahashi, R. (2026) · Journal of Neurochemistry · doi:10.1111/jnc.70500 · Cited by 3
“Similarly, stem cell–based studies in rodent and non-human primate models have shown that engrafted and differentiated cells can restore motor function through dopaminergic reinnervation (Doi et al. 2014, 2020; Kikuchi et al. 2017).”
InfluentialSelf-citationYan, Q. W., Xu, C., Gao, J., Wang, P., Wu, Q., Jin, Y., Lu, B., Li, M., Shao, M., Li, B., et al. (2026) · Advanced Science · doi:10.1002/advs.76394 · Cited by 1
Induced pluripotent stem cells from discovery to translation
Lee, J., Herron, T. J., Studer, L., Mummery, C. L., & Wu, J. C. (2026) · Nature Medicine · doi:10.1038/s41591-026-04584-3 · Cited by 3
“Embedding maturation state 177,178 , subtype composition 16,135 and potency-linked benchmarks into manufacturing strategies will further promote indication-level standardization and reproducible performance across patients.”
Electrophysiological Quality Control of Human Dopaminergic Neurons: Are We Doing Enough?
Seutin, V. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.715273 · Cited by 1
“What do we hope from these cells? A large fraction of them will probably degenerate and an additional pool will stop expressing TH: indeed TH expression was observed in about 30% of surviving cells in a monkey study (Kikuchi et al., 2017).”
BackgroundResultNeurotransplantation: the time has come?
Illarioshkin, S. N. (2018) · Annals of Clinical and Experimental Neurology · doi:10.25692/acen.2018.5.2 · Cited by 1
Organoids: the third dimension of human brain development and disease
Kouroupi, G., Prodromidou, K., Papastefanaki, F., Taoufik, E., & Matsas, R. (2021) · The International Journal of Developmental Biology · doi:10.1387/ijdb.210158gk · Cited by 1
Novikoff, S., Câmara, N. O. S., & Semedo, P. (2022) · Springer eBooks · doi:10.1007/978-3-031-11570-7_3 · Cited by 1
Contributions of stem cell engineering to new therapies for joint and bone diseases
Chen, H., Fu, X., & Liang, C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91938-8.00009-3 · Cited by 1
[Directed differentiation of human induced pluripotent stem cells into midbrain].
Xu, J., Li, Y., Zhong, G., Fang, Z., Liu, C., Ma, C., Wang, C., Guo, Y., & Liu, C. (2023) · PubMed Central · doi:10.12122/j.issn.1673-4254.2023.02.03 · Cited by 1
Kato, T., Nishimura, K., Hirao, M., Shimohama, S., & Takata, K. (2023) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12361 · Cited by 1
SinCMat: A single-cell-based method for predicting functional maturation transcription factors
Barvaux, S., Okawa, S., & del Sol, A. (2024) · Stem Cell Reports · doi:10.1016/j.stemcr.2023.12.006 · Cited by 2
Cheng, J., Zhang, B., Cai, W., Zhao, S., Deng, X., Wang, B., Zhu, X., Lv, Y., Zhu, W., Zhang, X., et al. (2024) · Fundamental Research · doi:10.1016/j.fmre.2024.03.003 · Cited by 1
“Human pluripotent stem cells (PSCs), including human embryonic stem cells (ESCs) and human induced pluripotent stem cells (iPSCs), possess capabilities for unlimited self-renewal and differentiation into encouraging functional outcomes [7–9] .”
Feng, S., Zhang, T., He, Z., Zhang, W., Chen, Y., Yue, C., & Jing, N. (2024) · Cell Regeneration · doi:10.1186/s13619-024-00191-0 · Cited by 1
“2), consistent with previous observation (Kikuchi et al. 2017) that few or no CD45 + lymphocytes infiltrated into human iPS-derived grafts at 12 months p.t. in PD cynomolgus monkeys with long-term Tacrolimus (also a calcineurin inhibitor, CNI) treatment.”
ResultWihadmadyatami, H., & Kusindarta, D. L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15717-2.00120-7 · Cited by 1
The loaded matrix: neurotrophin-enriched hydrogels for stem cell brain repair in Parkinson’s disease
Comini, G., & Dowd, E. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00586 · Cited by 1
“Although differentiation has previously been estimated at between 6% and 54% in preclinical studies (Kikuchi et al., 2017), we revealed it to be substantially lower than this with a median of just 3% of progenitors differentiating in the brain after transplantation.”
Therapeutic Strategies in Neurodegenerative Diseases
Eid, A. M., Faridar, A., & Appel, S. H. (2024) · Springer eBooks · doi:10.1007/978-3-031-68237-7_39 · Cited by 2
Carey, R. J., & Carey, J. L. (2017) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2017.10.009 · Cited by 1
Thérapie cellulaire et cellules souches en 2018
Magalon, J., François, P., Velier, M., Grimaud, F., Véran, J., Calmels, B., & Sabatier, F. (2018) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(18)30355-1 · Cited by 4
The Bioengineering of Exogenic Organs and/or Cells for Use in Regenerative Medicine
Aravalli, R. N., Shiao, M. L., Lu, W.-C., Xie, H. M., Pearce, C., Toman, N. G., Danczyk, G., Sipe, C. J., Miller, Z. D., Crane, A. T., et al. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813068-1.00015-4 · Cited by 1
Mechanisms and Clinical Applications of Stem Cell Therapy
Tora, M. S., Poth, K. M., Hardcastle, N., Sandor, K. P., Anthony, C., Di, L., & Boulis, N. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813997-4.00008-6 · Cited by 1
The therapeutic potential of exogenous adult stem cells for the injured central nervous system
Smith, J. A., Braga, A., Hamel, R., Rutigliani, C., Yu, B., Peruzzotti‐Jametti, L., & Pluchino, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818084-6.00006-4 · Cited by 1
Doi, D., & Takahashi, J. B. (2020) · Drug Delivery System · doi:10.2745/dds.35.4 · Cited by 1
Self-citationIn situ neuroregeneration: frontiers and therapeutic prospects
Wang, Q., Li, W., Lei, W., Chen, W., Zheng, J., Xiang, Z., MinHui, L. I. U., He, Q., Xu, L., Li, Z., et al. (2021) · Scientia Sinica Vitae · doi:10.1360/ssv-2021-0024 · Cited by 1
Selbstreproduktion: Zellteilung, Krebs, Stammzellen und Epigenetik
Plattner, H. (2021) · Springer eBooks · doi:10.1007/978-3-662-62118-9_12 · Cited by 1
Moral Recognition and the Limits of Impartialist Ethics: On Androids, Sentience, and Personhood
Schüklenk, U. (2021) · Oxford University Press eBooks · doi:10.1093/oso/9780192894076.003.0008 · Cited by 1
Role of stem cell therapy in neurosciences
Sharma, S., Jeyaraman, M., & Muthu, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821776-4.00012-3 · Cited by 1
Therapeutic Applications of Induced Pluripotent Stem Cell Use in Parkinson’s Disease Models
Baniadam, K., Tranchina, S., Lawlor, M.-K., & Kakazu, J. (2021) · Georgetown Medical Review · doi:10.52504/001c.29784 · Cited by 1
Zelltypen aus menschlichen pluripotenten Zellen und deren Anwendung in Zelltherapien
Zimmermann, W., Ader, M., Besser, D., Kronstein‐Wiedemann, R., Lickert, H., Schlüssel, E., Thiel, J., & Tonn, T. (2023) · Springer eBooks · doi:10.1007/978-3-662-67908-1_13 · Cited by 1
Microfluidic Chip for Label-Free Removal of Teratoma-forming Cells from Therapeutic Human Stem CellsPreprint
Wellmerling, K., Lehmann, C., Singh, A., & Kirby, B. J. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/830588 · Cited by 1
López-Ornelas, A., Escobedo-Ávila, I., Ramirez‐Garcia, G., Lara-Rodarte, R., Meléndez-Ramírez, C., Urrieta-Chávez, B., Barrios‐García, T., Cáceres-Chávez, V. A., Flores-Ponce, X., Carmona, F., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.08.192591 · Cited by 1
Transcription Factor-Mediated Differentiation of Human iPSCs into Neurons v1Preprint
Fernandopulle, M. S., Prestil, R., Grunseich, C., Wang, C., Gan, L., & Ward, M. E. (2019) · doi:10.17504/protocols.io.54rg8v6 · Cited by 1
Methods to Construct Biological Neural CircuitsPreprint
Lissek, T. (2022) · Preprints.org · doi:10.20944/preprints202208.0157.v1 · Cited by 1
APCDD1 outperforms other dopaminergic cell surface markers in benchmarking studyPreprint
Kirkeby, A., Schörling, A. L., Hänninen, E., Rifes, P., Salvador, A., Holm, A., Rathore, G. S., Nelander, J., Christiansen, J. R., Jensen, S. M., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3266974/v1 · Cited by 1
Self-citationCurle, A. J., Fazal, S. V., Qarin, S., Howlett, S., He, X., Barker, R. A., & Jones, J. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.23.576826 · Cited by 1
Comini, G., & Dowd, E. (2024) · bioRxiv · doi:10.1101/2024.03.28.587203 · Cited by 2
Human Stem Cell Therapy Is Successful in Monkeys with Parkinson Disease
Komaroff, A. L. (2017) · Journal watch · doi:10.1056/nejm-jw.na45013
Design and Application of Cell Glue
Teramura, Y. (2018) · KOBUNSHI RONBUNSHU · doi:10.1295/koron.2017-0052
Stem Cell-based Therapy for Parkinson’s Disease
Takahashi, J. B. (2018) · Japanese Journal of Neurosurgery · doi:10.7887/jcns.27.874
Self-citationDirect Reprogramming of Human Cell Lines in vitro Towards a β-Cell Phenotype
Ryan, N. (2018) · University of Minnesota Digital Conservancy (University of Minnesota)
Adult Neurogenesis in Health and Disease
Mobley, A. S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-811014-0.00008-1
Toyoda, T., Kimura, A., Tanaka, H., & Osafune, K. (2019) · Journal of Visualized Experiments · doi:10.3791/57641 · Cited by 1
Metadata
- Authors
- Kikuchi, T., Morizane, A., Doi, D., Magotani, H., Onoe, H., Hayashi, T., Mizuma, H., Takara, S., Takahashi, R., Inoue, H., Morita, S., Yamamoto, M., Okita, K., Nakagawa, M., Parmar, M., & Takahashi, J.
- Affiliations
- Kyoto University (JP)
- RIKEN (JP)
- Lund University (SE)
- Corresponding author
- Takahashi, Jun
- ORCID
- Venue
- Nature
- Published
- 2017-08
- Volume
- 548
- Issue
- 7669
- Pages
- 592-596
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2751466955
- Cited by
- 702
- References
- 48
- Citations by year
- 2026: 33 · 2025: 53 · 2024: 74 · 2023: 69 · 2022: 91 · 2021: 89 · 2020: 123 · 2019: 88 · 2018: 75 · 2017: 6
- FWCI
- 32.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- Japan Society for the Promotion of Science (15H02502, 15H02540, 16H03306, 15K12779, 16H03300)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- Parkinson's disease, dopaminergic neurons, induced pluripotent stem cells, cell transplantation, nonhuman primate model, Macaca fascicularis, MPTP-induced neurotoxicity, midbrain dopaminergic neurons, spontaneous movement, neurite outgrowth, corin, tumor formation, cell survival, cell tracking, immune response, cell therapy
- MeSH terms
- Adult, Aged, Aged, 80 and over, Animals, Cell Survival, Disease Models, Animal, Humans, Macaca fascicularis, Magnetic Resonance Imaging, Male, Mesencephalon, Movement, Parkinson Disease, Serine Endopeptidases, 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine, Neurites, Neostriatum, Regenerative Medicine, Cell Proliferation, Positron-Emission Tomography, Induced Pluripotent Stem Cells, Dopaminergic Neurons
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.